AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Prognostic Value of Ambulatory and Home Blood Pressure Beyond the PREVENT Equation

By Narita K, Abdalla M, Shimbo D et al.

Introduction: The Predicted Risk of Cardiovascular Disease EVENTs (PREVENT) equation is recommended for cardiovascular risk assessment to guide primary prevention strategies. PREVENT includes office systolic blood pressure (SBP), whereas ambulatory BP monitoring (ABPM) and home BP monitoring (HBPM) predict cardiovascular disease (CVD) better than office BP. Clarifying the additive prognostic value of ABPM and HBPM beyond PREVENT may help improve risk stratification in the management of hypertension. Research Question: We examined whether ABPM and HBPM readings are associated with CVD risk independent of PREVENT-predicted risk and whether they improve risk prediction beyond PREVENT. Methods: This post hoc analysis used two nationwide Japanese cohorts: the Japan Ambulatory Blood Pressure Monitoring Prospective (JAMP) study as the ABPM cohort and the Japan Morning Surge-Home Blood Pressure (J-HOP) study as the HBPM cohort. Participants with prevalent CVD, those outside the age of 30-79 years, and those with missing or outlier variables required for PREVENT calculation were excluded. ABPM parameters included 24-hour, daytime, and nighttime SBP and nocturnal dipping pattern, defined by SBP decline from daytime to nighttime: extreme dipper ≥20%; dipper ≥10% to <20%; non-dipper ≥0% to <10%; and riser <0%. HBPM parameter was the average of morning and evening SBP. Total CVD outcome included coronary artery disease, stroke, and heart failure. Cox hazards models estimated HRs for ABPM and HBPM parameters before and after adjustment for PREVENT 10-year risk. Incremental prediction was evaluated by C-statistics, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: In the ABPM cohort, among 2,982 participants (mean age 65.1 years; 46.8% men; 75.5% taking antihypertensive medication), 92 events occurred during a median follow-up of 4.8 years (event rate 3.1%); mean PREVENT-predicted event rate was 7.0%. After adjustment for PREVENT-predicted risk, riser pattern was associated with total CVD risk compared with dipper pattern (HR 1.85; 95%CI 1.01 to 3.38) ( Table ). The difference in C-statistics by adding dipping pattern to PREVENT was +0.013 (95%CI –0.002 to 0.046; P=0.082). IDI was modestly improved by adding dipping pattern. In the HBPM cohort, among 3,156 participants (mean age 62.9 years; 44.7% men; 76.9% taking antihypertensive medication), 136 events occurred during a median follow-up of 5.2 years (event rate 4.3%); mean PREVENT-predicted event rate was 8.6%. After adjustment for PREVENT-predicted risk, home SBP was not associated with total CVD events ( Table ). Adding home SBP did not improve C-statistics, NRI, or IDI. Conclusion: In these cohorts, ABPM and HBPM provided limited incremental prognostic discrimination beyond PREVENT, although nocturnal BP phenotypes may retain independent prognostic significance.

doi.org/10.1161/circ.154.suppl_1.9546Biomarkers

AgingResearch.News